BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) saw a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 14,100 shares, an increase of 422.2% from the September 30th total of 2,700 shares. Based on an average daily volume of 106,100 shares, the short-interest ratio is presently 0.1 days.

BriaCell Therapeutics Stock Performance

BCTXW traded down $0.01 during trading hours on Friday, hitting $0.33. 1,793 shares of the company’s stock were exchanged, compared to its average volume of 73,656. The stock’s 50-day moving average is $0.29 and its two-hundred day moving average is $0.42. BriaCell Therapeutics has a 1-year low of $0.11 and a 1-year high of $2.60.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.